ArticleCPT: pharmacometrics & systems pharmacology2024

Modeling serum M-protein response for early detection of biochemical relapse in myeloma patients treated with bortezomib, lenalidomide and dexamethasone.

Yuki Otani et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.